Rochester Institute of Technology

RIT Scholar Works
Theses
5-2019

Drug Quality Assurance to Combat Counterfeit Streptomycin
using Facile, Low Cost Colorimetry
MaKayla R. Foster
mrf4737@rit.edu

Follow this and additional works at: https://scholarworks.rit.edu/theses

Recommended Citation
Foster, MaKayla R., "Drug Quality Assurance to Combat Counterfeit Streptomycin using Facile, Low Cost
Colorimetry" (2019). Thesis. Rochester Institute of Technology. Accessed from

This Thesis is brought to you for free and open access by RIT Scholar Works. It has been accepted for inclusion in
Theses by an authorized administrator of RIT Scholar Works. For more information, please contact
ritscholarworks@rit.edu.

Drug Quality Assurance to Combat Counterfeit Streptomycin
using Facile, Low Cost Colorimetry

By: MaKayla R. Foster

A thesis submitted in partial fulfillment
of the requirements for the degree of Master of Science
in the School of Chemistry and Materials Science in the
College of Science of the Rochester Institute of Technology

May 2019

Primary Thesis Advisor: Professor Scott Williams

School of Chemistry and Materials Science
College of Science
Rochester Institute of Technology
Rochester, New York

This is to certify that the Master’s Thesis of
MaKayla Foster
has been approved by the Thesis Committee as
satisfactory for the thesis requirement for the Master of
Science degree in Chemistry at the convocation of
May 2019
Thesis Committee:

Dr. Scott Williams, Primary Thesis Advisor

Dr. Michael Coleman, Graduate Program Coordinator

Dr. Hans Schmitthenner, Committee Member, SCMS

Dr. Lea Michel, Committee Member, SCMS

Dr. Suzanne O’Handley, Committee Member, SCMS

Dr. Michael Gleghorn, Committee Member, SCMS

ii

Title of Thesis:

Drug Quality Assurance to Combat Counterfeit Streptomycin using Facile, Low Cost
Colorimetry

I, MaKayla R. Foster, hereby grant permission to the Wallace Memorial Library of
Rochester Institute of Technology to reproduce my thesis in whole or in part so long as
any reproduction will not be for commercial use or profit.

Date:

Signature:

iii

Acknowledgements
I would like to express my sincerest gratitude to my adviser, Dr. Scott Williams. Through
you and your passion for chemistry, I have gained a new appreciation for inorganic
chemistry and have been able to broaden my knowledge of analytical techniques. Thank
you for all our discussions, brainstorming, pushing me outside of my comfort zone, and
your belief in me over the last two years. I would not have become the chemist or person
that I am today without your help and guidance and could not have asked for a better
mentor.
Thank you to my committee for all of your guidance through the past two years. A very
special thank you to Dr. Hans Schmitthenner. All your guidance and support through the
HPLC method development has truly been appreciated. Not only have you helped
through this project but you are the reason that I decided to go on to a Ph.D program in
bioanalytical chemistry. Your passion for different separation methods, our discussions,
and the countless hours you spent guiding me through my project have truly helped to
kindle my passion for analytical chemistry.
I would like to thank my lab mates: Amanda Marotta, Vanessa Hulse, Yang Goh, Scott
Humski, Alexander Knowles, and Joseph Race for all of the fun inside and outside of the
lab. I do not know what I would do without you. You have helped me in so many ways.
Finally, I would like to express profound gratitude to my parents and grandparents for
providing unfailing support and continuous encouragement throughout my years of
study. This accomplishment would not have been possible without you.

iv

Table of Contents
Table of Figures................................................................................................................... viii
Table of Tables ....................................................................................................................... x
List of Abbreviations ............................................................................................................ xi
Abstract..................................................................................................................................xiii
Chapter 1:Introduction .......................................................................................................... 1
Introduction ......................................................................................................................... 1
Problem Statement ............................................................................................................ 2
Reason for Interest ............................................................................................................ 2
Explanation of Problem..................................................................................................... 2
Chapter 2:Theoretical Basis of the Study ......................................................................... 4
Introduction ......................................................................................................................... 4
Functional Group Tests .................................................................................................... 4
Jones Oxidation for Primary and Secondary Alcohol .................................................... 4
Tollen’s Aldehyde Test. .................................................................................................... 5
Hard-Soft Acid Base (HSAB) Theory .............................................................................. 5
Chelate effect ...................................................................................................................... 6
Visual Color Perception: CIE Lab.................................................................................... 7
Color Perception ................................................................................................................ 8
Color Vision and Color Vision Deficiency ..................................................................... 8
Reflective Spectrodensitometer .................................................................................... 10
Beer’s Law ......................................................................................................................... 10
High Performance Liquid Chromatography (HPLC) .................................................. 11
Mass Spectrometry .......................................................................................................... 14
Chapter 3:Literature Review .............................................................................................. 16
Tuberculosis ..................................................................................................................... 16
Counterfeit Medication .................................................................................................... 18
Current Counterfeit Detection Methods ....................................................................... 19
Conclusion ........................................................................................................................ 21
Chapter 4: Problem Statement .......................................................................................... 22
v

Chapter 5: Materials and Methods .................................................................................... 23
Materials............................................................................................................................. 23
1945 method ...................................................................................................................... 23
Colorimetric Assay for Streptomycin ........................................................................... 23
Colorimetric Assay for Streptomycin with Various Salts ......................................... 24
Tris(maltonato)iron(III) Complex Synthesis ................................................................ 24
Freeze Drying .................................................................................................................... 24
UV-Vis and FTIR Spectroscopy ..................................................................................... 24
HPLC ................................................................................................................................... 25
Chapter 6: Results: Counterfeit Streptomycin Detection Method Development ..... 26
Chemistry........................................................................................................................... 26
Heat time ............................................................................................................................ 28
Base Concentration Optimization ................................................................................. 31
Hydrochloric Acid Concentration Optimization ......................................................... 32
Acetic Acid Concentration Optimization ..................................................................... 33
HCl vs Acetic Acid Color Complex ............................................................................... 35
Metal Salt Analysis ........................................................................................................... 36
Iron Acetate ....................................................................................................................... 39
Paper Test Using Iron Acetate Assay Procedure .......................................................... 39
Capsules ............................................................................................................................. 41
Testing Common Counterfeit......................................................................................... 42
Detection of Counterfeit Medications........................................................................... 44
Chapter 7: Results: Tris(maltonato)Iron (III) Characterization .................................... 45
pH Study ............................................................................................................................ 45
Chloride and Non-Chloride Containing Acid Analysis ............................................. 47
Hydration State of Iron (III) Chloride: A Solid-State Pellet Analysis....................... 50
Mole ratios UV-Visible Spectra ...................................................................................... 52
FTIR of the Hydrolysis of Streptomcyin....................................................................... 55

vi

Chapter 8: Summary and Conclusion ............................................................................. 57
Summary ............................................................................................................................ 57
Recommendations for Further Investigations ............................................................ 57
References ............................................................................................................................ 62

vii

Table of Figures
Figure 1: Observed and absorbed colors with the wavelengths at which they are
absorbed ................................................................................................................................. 11
Figure 2: Streptomycin's structure. ...................................................................................... 27
Figure 3: Hydrolysis of streptomycin to form maltol. .......................................................... 27
Figure 4: Chromatogram and spectrum of standard maltol. .............................................. 28
Figure 5: Chromatogram and spectrum of maltol formed through a 16-hour base
hydrolysis. ............................................................................................................................... 29
Figure 6: Chromatogram and spectrum of maltol after being heated for 10 minutes. .... 29
Figure 7: Chromatogram and spectrum of maltol after being heated for 3 minutes. ....... 30
Figure 8: Beer's Law plot of iron-maltol complex heated for 3 minutes (x=3 trials). ....... 31
Figure 9: Chromatogram and spectrum of maltol when streptomycin is degraded with
2.0 M NaOH. ........................................................................................................................... 31
Figure 10: Chromatogram and spectrum of maltol when streptomycin is degraded with
0.55 millimolar NaOH. ............................................................................................................ 32
Figure 11: Beer's Law plot of the current method using 0.7 M HCl. ................................. 33
Figure 12: Beer's Law plot of the current method with acetic acid instead of hydrochloric
acid. ......................................................................................................................................... 34
Figure 13: pH 0.62 iron-maltol solutions with increasing streptomcyin concentrations
made with hydrochloric acid. ................................................................................................. 35
Figure 14: pH 3.51 iron-maltol solutions with increasing streptomycin concentrations
made with acetic acid. ........................................................................................................... 36
Figure 15: Iron-maltol complexes from 0 (left) to 1 (right) molar streptomycin containing
0.003 M iron. ........................................................................................................................... 37
Figure 16: Copper-maltol complexes from 0 (left) to 1 (right) molar streptomcyin
containing 0.003 M copper. ................................................................................................... 37
Figure 17: Beer's Law analysis of iron-maltol complex...................................................... 38
Figure 18: Beer's Law analysis of copper-maltol complex. ............................................... 38
Figure 19: Paper assay ranging from 0 to 148 mg/mL streptomycin ................................ 40
Figure 20: Beer's law analysis of iron-maltol complex on the paper test when solid iron
acetate was added to the solution. ....................................................................................... 40
Figure 21: Beer's Law analysis of the iron-maltol complex when gelatin capsules are
used to add the iron acetate.................................................................................................. 42
Figure 22: Counterfeit detection test used on common counterfeits. ............................... 43
Figure 23: Range of standard iron (III) maltol complexes at different pH’s adjusted with
HCl and NaOH........................................................................................................................ 46
Figure 24: An example of how the chelate effect influences complex stability. ............... 47
Figure 25: A tris(maltonato)iron(III) solution was adjusted to pH 2 using HCl (left),
adjusted to pH 4 with NaOH (middle), the same sample adjusted back to pH 2 with HCl
(right). ...................................................................................................................................... 48
viii

Figure 26: A tris(maltonato)iron(III) solution was adjusted to pH 2 using HCl (left),
adjusted to pH 4 with NaOH (middle), the same sample adjusted back to pH 2 with
phosphoric acid (right). .......................................................................................................... 48
Figure 27: Molecular orbital diagram for octahedral iron complexes ................................ 49
Figure 28: Reflective absorption spectrum of ferric chloride hexahydrate (blue) and
anhydrous ferric chloride (orange) ........................................................................................ 51
Figure 29: FTIR spectrum of ferric chloride hexahydrate .................................................. 51
Figure 30: FTIR spectrum of anhydrous ferric chloride ..................................................... 52
Figure 31: UV-visible Spectrum of the 1945 method at pH 2 (yellow) and mole ratios 1:1
(blue), 1:2 (orange), and 1:3 (gray) of ferric chloride: maltol at pH 2. ............................... 53
Figure 32: UV-visible Spectrum of the 1945 method at pH 5 (yellow) and mole ratios 1:1
(blue), 1:2 (orange), and 1:3 (gray) of ferric chloride: maltol at pH 5 ................................ 53
Figure 33: FTIR Spectrum of standard maltol .................................................................... 55
Figure 34: FTIR Spectrum of the 1945 method .................................................................. 55
Figure 35: FTIR of the 1:3 mole ratio (ferric chloride hexahydrate: maltol) ..................... 56

ix

Table of Tables
Table 1: List of common elements and compounds and their grouping in HSAB theory .. 6

x

List of Abbreviations

A

Absorbance, used in Beer’s Law Calculations

a*

Degree of redness or greenness

b

Pathlength, used in Beer’s Law Calculations

b*

Degree of yellowness or blueness

c

Concentration, used in Beer’s Law Calculations

CAMM

Chemical Assay to verify quantity and quality of Malaria Medications

CIE

International Commission on Illumination,

CIELAB

Uniform visual spacing of correlated colors

DESI

Desorption Electrospray Ionization

DQA

Drug Quality Assurance

FTIR

Fourier-Transform Infared Spectroscopy

GHB

Gamma-Hydroxybutyrate, commonly used as a date rape drug

GPHF MiniLab

Global Pharma Health Fund Minilab

HCl

Hydrochloric Acid

HPLC

High Performance Liquid Chromatography

HSAB

Hard Soft Acid Base

LC-MS

Liquid Chromatography-Mass Spectrometry
xi

L*

Lightness of color

MS

Mass Spectrometry

m/z

Mass to charge ratio of ions

NaOH

Sodium Hydroxide

NIR

Near InfraRed Spectroscopy

PADs

Paper Analytical Devices

TB

Tuberculosis

TLC

Thin-layer Chromatography

USAID

United States Agency for International Development

USD

U.S. Dollar

UV

Ultraviolet

WHO

World Health Organization

ε

Molar Absorptivity

xii

Abstract
An easy to use, low cost colorimetric method to identify the quality and quantity
of the tuberculosis (TB) medication, streptomycin was developed. TB is typically
treated using a multi-drug regimen comprised of antibiotics such as streptomycin.
According to WHO and USAID up to 50% of pharmaceuticals are counterfeit
worldwide. The problem intensifies the closer one gets to the point of care. A
facile counterfeit detection method, that is specific to only the authentic
medication, is essential. Since the 1940s, streptomycin was colorimetrically
identified using a 16-hour base hydrolysis process followed by an iron
complexation reaction. A tris(maltonato)iron (III) complex was suggested, but not
confirmed in the 1940s method. The maltol formation using a base hydrolysis
approach was optimized for streptomycin. Monitored using HPLC, the original 16hour hydrolysis time was reduced to 3 minutes using a heating process and a
two-fold reduction in NaOH concentration. A two-fold increase in maltol
hydrolysis per mole streptomycin was also achieved. The 2 M HCl acid, used to
catalyze the iron complex formation, was eliminated by using iron (II) acetate in
place of iron chloride in a capsule delivery system. The new assay system was
improved to include fewer steps and to remove caustic solutions thereby making
the reaction safer. In conducting optimizations to the 1945 method, we
discovered a discrepancy in the 1945 reaction interpretations. HPLC results
comparing the 1945 assay products with the known tris(maltonato)iron (III)
xiii

standard did not match. The solution colors were visually distinct. FTIR and
UV-visible Spectroscopic analysis suggested that the 1945 method was not
forming the tris(maltonato)iron (III) complex as reported. The safer and optimized
assay method, however, does make the tris(maltonato)iron (III) complex. An
effective, yet safer and better characterized colorimetric assay for streptomycin
was developed.
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Chapter 1
Introduction

Introduction
The World Health Organization’s (WHO) goal is to build a better and healthier
future through combatting disease, ensuring safe water, air, food and more.1 The WHO
is focused on many global health issues, however, there are two that the WHO is
particularly interested in. These are tuberculosis and malaria.2
In 2016, approximately 10.4 million people became ill with TB. TB is especially
dangerous because people can contract a multidrug resistant strain. If not properly
treated the results can be fatal. Streptomycin is commonly used to treat adults with a
resistance to the TB medication, Isoniazid, and to treat children with TB.3
Counterfeit medications have become a problem that is currently receiving
international attention.4 Medications are defined as counterfeit when they contain one or
more of the following: no active ingredient (placebos), actively harmful ingredients, fake
packaging or the incorrect quantities of active ingredients.5 The most harmful
counterfeiting method is when the concentration of the active ingredient is lower than
effective dose. This can lead to drug resistance, treatment failure, or death.6–8 This work
demonstrates that a simple colorimetric assay can be used to detect counterfeit
streptomycin as well as the detection of expired streptomycin. This colorimetric assay is
a modification of a 1945 reaction with the addition of metal complex characterization.

1

Problem Statement
Counterfeit medications are a worldwide problem. This problem is intensified
when the counterfeit medications are made with minute amounts of the active ingredient.
When people have TB or other diseases that have a multidrug resistant strain,
counterfeit medications can be fatal. A counterfeit detection method for the TB
medication, streptomycin, was studied to determine if there is a quantitative, facile and
low-cost authentication detection for streptomycin.
Reason for Interest
This project combined multiple interests of the researcher: forensics and
analytical chemistry. Merriam-Webster defines forensic as dealing with the application of
scientific knowledge to legal problems.9 This research deals with a huge legal problem
that leads to many deaths every year.
The researcher has an undergraduate degree in chemistry and did her capstone
research project with a concentration in analytical research using HPLC. Through this
work, the researcher was able to enhance her skills and knowledge using HPLC and
other analytical chemistry methods and techniques.
Explanation of Problem
An authentication test for streptomycin was studied. This is a low-cost
colorimetric assay that quantitatively and selectively identifies the streptomycin at the
point of care. In addition to testing the authenticity, this test can also detect when
streptomycin has expired. Strategies to detect other counterfeit medications were
developed through this process. Characterization of a critical organometallic complex

2

was then performed to understand the color differences of two different papers that
report that they are making the same complex.
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Chapter 2
Theoretical Basis of the Study

Introduction
This section states the reasons behind the measurements, test target choices
and the detection method techniques. The theories to follow set up the methods used for
this research, can be used to recreate this study or to conduct similar research.
Functional Group Tests
Structures can be identified and characterized using their functional groups.
There are different tests that can be performed to identify each functional group.

Jones Oxidation for Primary and Secondary Alcohol

The Jones reagent is 2.7 M chromic acid in 3.0 M sulfuric acid. When the orangeyellow reagent is added to a primary or secondary alcohol, a green-colored solution of
chromium sulfate is formed, see Equation 1. Aldehydes and enols give a positive test
result but tertiary alcohols do not. Phenols also result in a positive test, but the colored
product is not the characteristic blue green.

Primary alcohol is oxidized to aldehyde

Eq. 1

Orange

Cr6+ is reduced to Cr3+

4

Blue/Green

The aldehyde is
further oxidized into a
carboxylic acid

Tollen’s Aldehyde Test.
Equation 2 shows how the Tollen’s aldehyde test works.10

Eq. 2

Tollen’s reagent is made using 2 mL of 0.2 M silver nitrate and 1 drop of 3 M
sodium hydroxide. A 2.8% ammonia solution is added dropwise and shaken until almost
all silver oxide precipitate dissolves. This reagent can then be used to test for aldehydes
but will also result in a positive test for easily oxidized compounds such as aromatic
amines and some phenols. One drop or a few crystals of an aldehyde can be added to 1
mL of Tollen’s reagent. A positive result will be shown by a silver mirror or black
precipitate. If there are any oils in the test tube the silver mirror will not be observed. 10
Hard-Soft Acid Base (HSAB) Theory
Coordinate compounds may be thought of as Lewis salts or adducts which are
made from a combination of Lewis acids (electron acceptors) and Lewis bases (electron
donors). In a coordinate complex Lewis acids are the metal atom or the ion and the
Lewis bases are the ligands. Lewis acids and bases may be further separated into two
more categories: hard and soft.11 The hard acids and bases possess a common property
of being non-polarizable; that is, typically compact, highly charged and high
electronegativity. On the other hand, soft acids and bases are large, diffuse and
therefore polarizable. Soft acids bond with soft bases and hard acids bond with hard
bases. This theory is often used to empirically predict relative stabilities of transition
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metal complexes. There are tables that contain lists of the hard and soft acids and
bases, as seen in Table 1.12
Table 1: List of common elements and compounds and their grouping in HSAB theory
Hard Lewis Acids

Borderline Lewis Acids

H+, Na+, K+
Be2+, Mg2+, Sr2+

Soft Lewis Acids
Cu+, Ag+, Au+

Fe2+, Ni2+, Zn2+

Sc3+, Fe3+, Ln3+

Hard Lewis Bases

Borderline Lewis Bases

H2O, NH3, R2O
Cl-, NO3-

Soft Lewis Bases
RSH, R2S

Br-

I-, CN-

Chelate effect
Reactions are energetically driven either through the lowering of internal energy
or increasing system disorder. The overall reaction tendency to proceed to products is
governed by Gibb’s Free Energy (ΔG), Equation 3.
𝛥𝐺 𝑜 = 𝛥𝐻 𝑜 − 𝑇𝛥𝑆 𝑜

𝑬𝒒. 𝟑

The chelate effect explains the higher stability of coordination compound that
contain multidentate ligands than those containing monodentate ligands. This increased
stability can be explained by the entropy of the reaction. Before the ligands react with the
metal, the metal is bonded to six waters (hexa(aqua) iron (III)). Water bonds are broken,
and the metal then binds to the ligands. When the ligands are monodentate, one ligand
6

replaces one water and the number of reactants is the same as the number of products.
When the ligands are bidentate one ligand replaces two water molecules which
increases the number of products. When the number of products is higher than the
number of reactants there is a higher entropy on the products side of the reaction which
pushes the reaction forward. The entropy increases with more multidentate ligands. This
can be further explained through the free energy equation (Eq. 3) The higher the
entropy, the more negative Gibbs free energy is (ΔG). The calculated ΔG can then be
put into Eq. 4.
𝛥𝐺 𝑜 = −𝑅𝑇𝑙𝑛(𝐾)

𝑬𝒒. 𝟒

The more negative Gibbs free energy is, the larger the positive value for the equilibrium
constant, further proving that the multidentate ligands are more stable than the
monodentate ligands.12
Visual Color Perception: CIE Lab
The International Commission on Illumination (CIE) made a way to organize color
space (CIELAB). This is a uniform visual spacing that is correlated with color perception.
This three-dimensional model describes lightness, hue and chroma. L* represents the
lightness, a* is the redness or greenness and b* is the yellowness or blueness. The L*
that is used for this model is the Munsell lightness. Munsell’s lightness model considers
lightness of the background before looking at that of the object. CIELAB has the L* on
the z axis where the more positive the value of L*, the lighter it is. The a* value is on the
x axis and when it is positive it is more red and when it is negative it is more green. The
last value of b* is on the y axis, when it is positive it is more yellow and when it is
negative it is more blue.13
7

Color Perception
Color is based on perception and subjective interpretation. One object may look
like it is different colors to different people. This is due to different light sources,
backgrounds, directions, observers, and sizes. Every individual’s eyes are different,
even if someone has “normal” vision and “normal” color vision. The vision of human
beings can be biased towards certain colors, and can also change with age.14
Color Vision and Color Vision Deficiency
Humans can only perceive specific wavelengths as colors in the region known as
the visible region. This includes wavelengths from 300-800 nm. The region with the
longest wavelength is seen as red while the shortest is seen as violet. Light and color
stimulate the retina of the human eye which making the color vision possible.14
People can see in color due to photoreceptors that are in the retina of the eye.
The retina contains a thin layer of tissue at the back of the eye that contains millions of
these photoreceptors. The photoreceptors are shaped like rods and cones. The rods and
cones contain photopigment molecules that undergo a chemical change when absorbing
light. When excited, a chemical change acts like a switch. Once these signals are
triggered, the signals are passed from the retina to the visual parts of the brain. The rods
and cones serve different purposes once excited. Rods respond to dim lights and are
used for night vision. Cones are more responsive to bright light and are sensitive to long
(red), medium (green), and short (blue) wavelengths of light. Another difference between
the two is rods only contain one photopigment while the cones contain one of the three
different photopigments. The different photopigments allow the human eye to be
sensitive to different parts of the visual spectrum, allowing more rich color vision. Since
8

these pigments are all the same, most people have a very similar color experience. The
variations of the colors experienced by human beings stem from the way the eye and the
brain work together to translate light and color.15 The central part of the retina, called the
macula, is the part of the retina responsible for cones sensitivity to red, green or blue
light given their different wavelength sensitivities. A person becomes color vision
deficient if one of the light-sensitive pigments is missing.16
Color vision deficiency is when the person cannot distinguish between certain
shades of color. Color vision deficiency is commonly referred to as color blindness even
though there are very few people that are color blind. People that are color blind have a
condition called achromatopsia. When a person has achromatopsia they can only see in
black, white, and shades of gray. Color vision deficiency can range in severity from mild
to severe and can be inherited or cause by illness or injury. If the deficiency is caused by
an illness or injury it can affect one or both eyes. Genetically inherited deficiencies
usually affect both eyes. When color vision deficiency is inherited, it is linked to the X
recessive gene; therefore, men are more likely to be color vision deficient. Approximately
0.5% of women are color vision deficient while 8% of males are color vision deficient.16
Color vision deficiency is diagnosed through a comprehensive eye exam. In this
exam, the patient is shown pseudoisochromatic plates, also known as Ishihara plates.
These plates are a series of specifically designed pictures designed within colored dots.
People that have normal color vision see a number, but those who are color vision
deficient do not.16

9

Reflective Spectrodensitometer
Reflective spectrodensitometers are commonly used in printing. These
instruments measure process colors. Process colors are cyan, magenta, yellow and
black. They are also used to check the density of the color.17
Beer’s Law
Beer’s Law states that absorbance is directly proportional to the concentration of
the light absorbing species. This is explained using equation 5.
𝐴 = 𝜀𝑏𝑐

𝑬𝒒. 𝟓

Where A is the absorbance, c is the concentration, b is the pathlength and ε is the molar
absorptivity or extinction coefficient. The molar absorptivity is a way to characterize the
substance by how much light it absorbs for a specific wavelength. This coefficient is the
proportionality constant between the absorbance and the product of the pathlength and
concentration, the greater epsilon the greater the absorbance given a fixed chromophore
concentration and pathlength. Using Beer’s Law, an absorption spectrum can be made.
An absorption spectrum is a graph that shows the absorbance or molar absorptivity at
various wavelengths.18
The atom or group known as a chromophore is an important part of this process
and is responsible for the light absorption that is being analyzed. A molecule that absorbs
visible light appears to have a specific color. The human eye detects the colors that are
transmitted or reflected. These colors are complimentary colors to what is being
absorbed.18 A list of the colors absorbed and observed, along with the wavelengths that
the colors are absorbed at can be seen in Figure 1.
10

Approximate
Observed Color

Color of Light

Wavelength of

of Compound

Absorbed

light Absorbed

Green

Red

700 nm

Blue-green

Orange-red

600 nm

Violet

Yellow

550 nm

Red-violet

Yellow-green

530 nm

Red

Blue-Green

500 nm

Orange

Blue

450 nm

Yellow

Violet

400 nm

Figure 1: Observed and absorbed colors with the wavelengths at which they are
absorbed
High Performance Liquid Chromatography (HPLC)
HPLC is a separation method that uses high pressure to force a solvent through
a closed column containing fine particles, giving a high-resolution separation. This
system consists of a solvent delivery system, a sample injection valve, a high-pressure
column, a detector and a computer display system. The efficiency of the column is
dependent on the packed column. The smaller the stationary phase, the larger the plate
number, this higher plate number results in sharper peaks. As the particle size of the
stationary phase decreases the efficiency increases. The particle size of the stationary
phase typically ranges from 3-5 µm.18
11

The column is commonly steel or plastic and is 5-30 cm long with a 1-5 mm
diameter. All separation happens in the column, however, the column is easily degraded.
To protect the column, a guard column is used. The guard column contains the same
stationary phase as the main column, but it retains the fine particles and strongly
adsorbed solutes before they get to the main column. In some cases, the main column is
heated. This decreases the solvents viscosity, therefore reducing the pressure that is
needed to have a faster flow. This can improve the resolution, while decreasing the
retention times. One problem with heating the column is the stationary phase can
degrade and decrease the lifetime of the column.18
The stationary phase is most commonly highly pure, spherical, microporous
particles of silica. These silica particles are permeable to solvents. There are a few
limitations to using silica. One must avoid dissolving the silica in a pH above 8, otherwise
it dissolves. The other limitation is that the silica surface also contains some silanol
groups (Si-OH); these groups are protonated at a pH of approximately 2-3. These can
dissociate to Si-O- at a pH above 3. These protonated groups can also lead to tailing.
The biggest problem is that the siloxane bond goes through hydrolysis at a pH below 2.
The pH of anything analyzed on HPLC needs to be between 2 and 8.18
In adsorption chromatography, the solvent molecules compete with the solute
molecules for a place on the stationary phase. The solvent and solutes ability to elute
depends on their nature. Elution occurs when the solvent displaces the solute from the
stationary phase. In normal-phase chromatography, the adsorption is on bare silica. The
nature of the solvents depends on polarity. In this case, there is a polar stationary phase
with a less polar solvent. The more polar the solvent, the higher its eluent strength.
12

Reverse-phase chromatography is when the stationary phase is nonpolar while the
solvent is more polar. This has a higher eluent strength with less polar solvents.
Reverse-phase chromatography is more common in HPLC due to its more favorable
results, such as, the stationary phase having fewer sites that strongly adsorb the solute,
leading to less tailing and it is less sensitive to polar impurities.18
There are two different elution methods that can be used. The first is isocratic
elution, this is when a single solvent or a constant mixture of solvents is used. The other
is gradient elution, this is when there are increasing amounts of solvent B added to
solvent A to create a continuous gradient. Solvent A is commonly an aqueous solvent
and solvent B is an organic solvent. A gradient elution leads to more separation and is
faster. The solvents used are very pure HPLC grade solvents that are required to
prevent the degradation of the column.18
In HPLC, the peaks should always be narrow and symmetric to show full
separation. To maintain this symmetric band, shape the column should be washed
periodically to prevent strongly adsorbed compounds from building up on the silica. If the
sample solvent has a larger eluent strength than the mobile phase with a double peak
may be seen. The volume before the injection is called dead volume. This needs to be
accounted for by subtracting this time from the time that the peaks are seen.

18

How steady and reproducible the flow of solvent is in the HPLC is determined by
the quality of the instrument. This steady flow minimizes the noise. The injection valve
has interchangeable sample loops that holds a fixed volume. When the injection valve is
in the load position, a syringe is used to wash and load the loop with the fresh sample at
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atmospheric pressure. When the valve is rotated 60° counterclockwise, the sample
contents that are in the sample loop are injected to the column at a high pressure.
Once the sample is injected and is separated in the column, it is eluted off the
column and passes through a detector. There are many different detectors that can be
used. Ultraviolet detectors using a flow cell are very common. These absorb the
ultraviolet or visible light. The photodiode array is used to record the spectrum for each
solute that is eluted.18
Mass Spectrometry
The mass spectrometer characterizes molecules through the measurement of
the molecular weight of each molecule. Individual molecules are converted to ions,
which are then moved and manipulated by electric and magnetic fields. The main
components of the mass spectrometer are the ion source, mass analyzer and the
detector. The ions to be measured are under pressure, and this can be done in a few
different ways. One of the common procedures is that ionization is affected by a beam of
high energy electrons, the ions are then separated by accelerating and focusing the ions
in the beam. This beam is bent by the external magnetic field and the ions can then be
detected.18
High energy electrons collide with molecules, breaking apart and ionizing the
molecules. The energy from the collision may cause the molecular ion to fragment into
neutral pieces and smaller fragment ions. These fragments can be radical cation,
carbocations, or neutral. Fragments can fragment further into smaller parts.18

14

A mass spectrum looks like a vertical bar graph, where the bars represent the
ions mass-to-charge ratio (m/z). The length of the bar represents the relative abundance
of the ions, with the highest abundance being 100. The relative abundance of 100 is
referred to as the base peak. The ion with the highest mass in the spectrum is usually
considered to be the molecular ion and the lower mass ions are usually fragments, this
is assuming that the sample is a single and pure compound.18
Mass spectrometers separate and detect ions based on their exact masses.
These ions can be detected when they have slightly different masses, such as with
isotopes. Common types of mass spectrometry are quadrupole, time-of-flight, orbitraps,
and ion traps.18
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Chapter 3
Literature Review

Tuberculosis
TB is one of the world’s most deadly diseases with 10.0 million cases of TB in
2017.3 This totaled to 1.3 million deaths among HIV-negative people and 300,000 deaths
from TB from HIV-positive people.3 TB is a worldwide problem, even affecting the United
States.19
In the US alone, there were a total of 9,105 TB cases in 2017.3 This is often
surprising to people because TB is thought to be an “old disease.”20 TB is one of the
oldest infectious diseases to affect mankind. A 4,000 year old skeleton’s cause of death
was determine to be from TB.21 TB was thought to be under control in the 1980s and
there were predictions that it could be eliminated completely, however, it is still prevalent
today. Unfortunately, TB came back stronger than ever, this time with multi-drug
resistant strains that continue to spread.22 TB came back so strongly because HIV
depresses the immune system making it easier for people to contract TB. Today, TB is
one of the top 10 causes of death worldwide.3
TB is caused by a bacterium known as Mycobacterium Tuberculosis.21,23–25 This
bacterium can affect a person’s bones, central nervous system and other organ systems
but it most commonly is seen in the lungs. Mycobacterium Tuberculosis is contained in
aerosol droplets on the lung alveolar surfaces. This makes it easy to transmit through
the air.25,26 When a person sneezes, coughs, or spits the bacterium is propelled through
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the air. One third of the world’s population has latent TB because it is so easily
transmitted. Latent TB is when the person is infected but is not yet ill. The active form of
TB is when the person will show symptoms and start being able to spread the disease to
others. Initial symptoms are very mild including chills, a cough, fever, fatigue, night
sweats, no appetite, weight loss, and can progress to a bloody cough. Since the
symptoms are so mild and resemble the symptoms of a common cold for months, there
is a delay in the infected person seeking the medical attention that is necessary to avoid
the transmission. Without the proper treatment two thirds of the people that have the
active Mycobacterium Tuberculosis bacterium die. Properly diagnosed and treated TB is
both curable and preventable.25 The treatment for TB is most commonly a multidrug
regimen, also called chemotherapy.27
TB has a long history. The first TB medication was invented during World War II
when a biochemist by the name of Frederick Bernheim was working at Duke University
in North Carolina. At the time he believed that the war was increasing the number of
people that were suffering from and dying from TB. For this reason, he came up with one
of the first medications to treat TB, which was an aspirin derivative. Then, in 1943
streptomycin was discovered. This was less toxic to animals than the first medication but
had very similar properties. The first set of clinical trials started in 1944 and were
successfully completed. The limitations to streptomycin use were that it had to be
injected and the patients with long term treatment quickly grew a resistance to the
medication.28
Patients with the drug resistant strain have a high risk for treatment failure,
relapse, further resistance, or even death. TB treatment consists of first-line regimens
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plus require the use of four to six antimicrobial medications over a six-month period. The
most common frontline medications are: isoniazid, rifampicin, ethambutol, and
streptomycin. Resistances to these medications can be caused by the anti-TB
medication being used inappropriately. This is done through incorrect prescriptions
provided by the health care providers, poor quality medications, patients stopping their
treatment prematurely, and counterfeit medications.24
Counterfeit Medication
The counterfeiting of medications has become a two hundred billion dollar annual
business.29 Many counterfeit medications are made from chalk, corn starch, potato
starch, paracetamol tablets and co-trimoxazole tablets.5,30 Counterfeit medications are
currently receiving international attention which has also increased public awareness.31
WHO has estimated that 10% of the world’s pharmaceutical trade and 25% of the trade
in developing countries is counterfeit.32,33
Counterfeit drugs are medications that are deliberately and fraudulently
mislabeled. This could mean that they contain no active ingredients (placebos), actively
harmful ingredients, have fake packaging, or incorrect quantities of the active
ingredient.5 The counterfeit medications often have the same packaging, pill color, pill
shape, pill size, marking, and the package may have an electronic barcode that the
pharmacist can scan. The most harmful counterfeiting method is when the medication
has a low concentration of the active ingredient because it can lead to drug resistance.6
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Current Counterfeit Detection Methods
There are several current detection methods for counterfeit medications. These
include: HPLC, TLC, mini-lab, mass spectrometry, near infrared spectroscopy, and x-ray
powder diffraction.6
When TLC is used to identify counterfeits, it is only semiquantitative. TLC
detection methods can be evaded by adding a small amount of the active ingredient to
the counterfeit medication. HPLC, mass spectrometry and x-ray powder diffraction are
all instrument-based detection methods. These instruments are expensive, require
stable electrical power supplies, and a skilled technician to operate them.34
The Global Pharma Health Fund (GPHF) Minilab35 was created with the objective
to make a kit with inexpensive field tests containing simple methods for rapid drug
quality verification and counterfeit medication detection. This kit contains a manual that
is printed in many languages and the kit can be shipped anywhere in the world. To make
these tests low-cost, the kits contain the supplies for 1,000 assays but none of the tests
exceed two euros (2.35 USD). Everything that is needed to perform these tests are
compacted into a single, heavy duty suitcase. Each kit includes: glassware for sample
extraction, preparation, pipetting, spotting, high performance chromagraphic plates,
developing chambers, detection chambers, an electronic pocket balance, UV lamps with
different wavelengths, a hotplate, a ruler, pens and pencils. Even though each individual
test in the kit is inexpensive, one kit with all materials ranges from 10,000-20,000 USD.35
Additional options for products can be added to the supplies listed above.
In some parts of the world there is a limited capacity and limited number of
trained chemists. There are also a limited number of reference materials that the
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samples can be referenced with and compared to. The methods that are used for field
detection of counterfeits in developing countries needs to be portable, relatively easy to
use, sturdy, and inexpensive, while still providing the user with reliable and useful data.
This is a hard set of demands to meet given the more reliable methods typically result in
more expensive test kits that cannot always be used in the field.34
Colorimetry is mostly used to quantitatively detect counterfeit medications. Even
though colorimetry is a technique that destroys the samples and gives limited
information, these tests are considered invaluable to field inspectors for ease of use and
reduced expense. To make colorimetry a more quantitative technique a photometer can
be used.34
A quantitative counterfeit detection method was made for Malaria medications by
South Dakota School of Mines and Rochester Institute of Technology. This is a chemical
assay to verify the quantity and quality of malaria medications (CAMM). The active
ingredient sesquiterpene lactone was targeted for this colorimetric assay. This test result
turns purple when the active ingredient is present. This can then be compared to a blue
violet Crayola crayon. If it matches the crayon, the correct quantity of the active
ingredient is present. This particular test is performed in a test tube.36
Low-cost paper analytical devices (PADs) were made at Notre Dame to detect
low-quality medications. These PADs are cards that can quickly determine if the drug
contains the correct medication. They are cheap and easy to use, do not require power,
chemicals, solvents, or any expensive instrumentation. They also can be deployed
rapidly at a large scale when there is a suspected problem with the pharmaceutical
quality. PADs have been made for 60 different pharmaceuticals.37
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Green et al. developed methods that characterize counterfeit medications using
Liquid Chromatography-Mass Spectrometry (LC-MS), raman spectroscopy, near IR
spectroscopy (NIR), and desorption electrospray ionization (DESI) MS at Georgia
Institute of Technology.38–46 All of these methods, plus a handheld device were used to
study the antimalarial medication, artesunate.38,40,44 DESI-MS is a rapid and quantitative
method that probes the solid surface of the artesunate and Tamiflu capsules.39,41 DESIMS proved the top two layers of the capsules were authentic. Raman spectroscopy was
used because it can discriminate between genuine and counterfeit tablets quickly.40,43 A
handheld instrument was also developed to detect counterfeit artesunate tablets using a
visual fluorescence comparison. This counterfeit detection device contains an LED light
source that covers the UV to IR region and a handheld microscope. The device can be
used in real time for onsite comparisons of the pharmaceutical dosage and the
packaging of the medications.44
Conclusion
There have been tests that have been made for counterfeit malaria and diabetes
medications, but it seems that there has not been much research on TB medications.
The scope of reliably, verifiable medications, utilized in great quantities the world over,
could be broader.
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Chapter 4
Problem Statement

WHOs could use assistance with research dedicated to reducing a major
communicable disease like TB, while at the same time curbing the quantity of antibiotic
resistant strains of diseases. Development of a simple and low-cost colorimetric assay
that quantitatively and selectively identifies the frontline TB medication, streptomycin,
could serve as an authentication test. This test was targeted for point of care
implementation while simultaneously meeting the requirements of simplicity, low cost,
and minimal training for those with limited resources.
Streptomycin was analyzed considering its use to treat children and people who
have a TB strain that is resistant to isoniazid, a drug commonly used to treat TB.3 An
established colorimetric assay was then studied and modified to improve the
implementation requirements. A roadmap to aid future researchers in developing simple,
low-cost, and quantitative colorimetric tests for identifying other medications will be
provided.
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Chapter 5
Materials and Methods
Materials
Streptomycin sulfate, iron (II) acetate 95%, iron (III) chloride hexahydrate 99+%
and standard 3-hydroxy-2-methyl-4-pyrone 99% (maltol) were purchased from Acros
Organics and used without further purification. Sodium hydroxide pellets and glacial
acetic acid were purchased from Macron Fine Chemicals. Size 0 gelatin capsules were
used in this study. All HPLC grade solvents (Acetic Acid and Methanol) were obtained
from J.T. Baker.
1945 method
Colorimetric assay in accordance to Schenck with overnight reaction time for
maltol formation was performed without modification.47
Colorimetric Assay for Streptomycin
Samples were prepared using 58 mg/milliliter stock solution of streptomycin in
water. Streptomycin concentrations ranged from 0 to 145 mg/mL in each assay trial.
These solutions were combined with 0.5 milliliters of 1.1 M NaOH. Water quantities of
6.5, 6.0, 5.5, 5.0, 4.5 and 4.0 milliliters were added respectively. These assay trials were
heated at 55-75°C for three minutes. At the end of this time, samples appeared faintly
yellow in color due to the formation of a maltol. Next, a gelatin capsule containing 0.05
grams of iron acetate was added to the solution while it was still hot and mixed to allow
the capsule to dissolve. This was repeated with each of the solutions. A red color
developed in each sample. One drop of each sample was added to a piece of filter
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paper. When the drops dried, they were orange, the intensity varying with the different
concentrations of streptomycin.
Colorimetric Assay for Streptomycin with Various Salts
Samples were prepared using 0.34 M stock solution of streptomycin in water.
Streptomycin concentrations ranged from 0 to 145 mg/mL in each assay trial. These
solutions were combined with 0.5 milliliters of 1.1 M NaOH. Water quantities of 6.5, 6.0,
5.5, 5.0, 4.5 and 4.0 milliliters were added, respectively. These assay trials were heated
at 55-75°C for three minutes. At the end of this time, samples appeared faintly yellow in
color due to the formation of a maltol. Next, 0.002 moles of copper, nickel, cobalt, and
iron salts was added to the solution while it was still hot.
Tris(maltonato)iron(III) Complex Synthesis
One mole of ferric chloride was dissolved in 50 mL of distilled water and 3 mole
of maltol in 50 mL of distilled water was stirred and slightly heated until dissolved. After
both solutions were dissolved they were mixed and diluted.
Freeze Drying
All samples that were freeze dried into powders were frozen with liquid nitrogen
and freeze dried using a Labconco FreeZone freeze drier.
UV-Vis and FTIR Spectroscopy
All UV-visible spectrums were analyzed from a Shimadzu UV-2600 UV-Vis
Spectrometer. All FTIR results were recorded from a Pike Technologies GladiATR ATRFTIR. All spectrodensiometer samples were recorded using an X Rite model 500
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Spectrodensiometer. The absorbance measurements of pellets were obtained using a
Coloreye 7000 Spectrophotometer.
HPLC
The HPLC instrument used was a Hewlett Packard Agilent Series 1100 with Diode
Array Detector and an Agilent column 1.0 mm by 100 mm and 3.5-micron particle size.
The injection size was 10.0 microliters. The flow rate was 0.5 mL/min with a mobile phase
gradient starting at 100% Solvent A (1% Acetic Acid) and 0% Solvent B (Methanol) to 0%
solvent A and 100% solvent B at eight minutes. A broad gradient is used to assay the
product relatively quickly (several minutes). Increasing the organic solvent to 100% also
ensures that there are no non-polar impurities.
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Chapter 6
Results: Counterfeit Streptomycin Detection Method Development

The first streptomycin detection method was developed in 1945 by Schenk et
al.47 This method uses a base hydrolysis step to break down streptomycin into maltol.
The maltol can then complex with iron using ferric salt.47 The 1945 method was later
updated to state that 5 mg of streptomycin should be tested with four milliliters of water.
This should be mixed with one milliliter of one molar sodium hydroxide and heated for
four minutes. The hydrolyzed products are then acidified by adding hydrochloric acid. A
violet color complex is formed by the addition of iron chloride.48 The updated method
was the starting point, in this study, to develop a point of care assay that would require
as little training as possible. Substantial advances and optimizations of the original
Schenk streptomycin authentication method are reported.
Chemistry
The colorimetric reaction consists of the hydrolysis of streptomycin, followed by
the iron chelation. The streptomycin (seen in Figure 2) first undergoes a base hydrolysis
(seen in Figure 3).
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Figure 2: Streptomycin's structure.

Figure 3: Hydrolysis of streptomycin to form maltol.
In Figure 3, the large streptomycin subgroups are abbreviated as St and Glm. In the first
step there is a ring expansion, where carbon 2 releases its bond to carbon 4 and binds
to carbon 3 instead. In step two, there is a keto-enol tautomerization. This is when the
ketone group on carbon 4 transfers its electrons to form a double bond between carbon
4 and carbon 5. There is an elimination point in step three where the large Glm
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streptomycin subgroup is released and a double bond is formed between carbon 2 and
carbon 3. Next, there is an enol-keto tautomerization step where the double bond
between carbon 2 and 3 transfers its electrons to carbon 3 and the alcohol on carbon 3,
then becomes a ketone. Another elimination occurs in the final step where the ST
streptomycin subgroup is released and a double bond is formed between carbon 1 and
carbon 3. The maltol product can be distinguished by its yellow color. After this
hydrolysis, maltol then reacts with iron acetate to form a tris(maltonato)iron (III) complex.
Heat time
The 1945 method stated that the reaction was left alone for 16 hours to form
maltol through base hydrolysis. The updated method stated that the reaction had to be
heated for 4 minutes in a hot water bath.47,48 First, a maltol standard was analyzed using
reserve phase HPLC (see Figure 4).

Figure 4: Chromatogram and spectrum of standard maltol.
The HPLC chromatogram of maltol after a 16-hour hydrolysis at room temperature is
shown in Figure 5.
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Figure 5: Chromatogram and spectrum of maltol formed through a 16-hour base
hydrolysis.
The Schenck method did not resolve a peak corresponding to that obtained with a maltol
standard (see Figure 5).
For this test to be a counterfeit test performed at the point of care, a much faster
assay must be developed. The reaction was heated to determine if maltol could be
formed faster through this process. The heating times that were studied started at ten
minutes at 55-80 °C. These heat times were first studied with HPLC, and then Beer’s law
analysis to determine linearity. Figure 6 shows the HPLC chromatogram for the tenminute heat time.

Figure 6: Chromatogram and spectrum of maltol after being heated for 10 minutes.
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Heating the streptomycin solution for 10 minutes resolved a maltol peak at 2.799
minutes with a peak area of 2513.02100 mAU*s. Additional peaks, however, at 4.436
and 5.777 minutes indicate the presence of nonpolar impurities. The heat time was then
decreased until these smaller peaks disappeared, and the area for the maltol peak
reached a maximum thereby indicating maximum maltol formation. The optimized heat
time and temperature was determined to be 3-minutes at 55 °C (Figure 7).

Figure 7: Chromatogram and spectrum of maltol after being heated for 3 minutes.
The HPLC peak area for the 3-minute heat time was 2605.95630 mAU*s. This suggests
that there is maltol being formed with 3 minutes of heat at 55 °C with no detectable
impurities. After the HPLC analysis was complete the 3-minute heat time was studied
using Beer’s Law analysis (see Figure 8).
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Figure 8: Beer's Law plot of iron-maltol complex heated for 3 minutes (x=3 trials).
Base Concentration Optimization
Sodium hydroxide concentration was varied to determine the optimal amount
required for the experiment. The concentration of sodium hydroxide was decreased from
the starting concentration of 2 M and was analyzed using reverse phase HPLC (see
Figure 9).

Figure 9: Chromatogram and spectrum of maltol when streptomycin is degraded with
2.0 M NaOH.
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The peak at 2.6 minutes had an area of 2814.52246 mAU*s when 1 millimole of NaOH
was used. After conducting a range of base concentrations from 0.4 to 1 millimole NaOH
the optimal concentration was determined to be 0.55 millimolar NaOH with a curve area
of 5381.96338 mAU*s, as shown in Figure 10.

Figure 10: Chromatogram and spectrum of maltol when streptomycin is degraded with
0.55 millimolar NaOH.
At 0.55 millimole of NaOH, nearly two times the maltol amount was formed. Maltol yield
formation was found to decrease when the base concentration was less than 0.55
millimole. The optimized base concentration resulted in pH reduction from 12.71 to
11.58.
Hydrochloric Acid Concentration Optimization
The 1945 method did not mention using hydrochloric acid and the updated
Pharmacopeia method stated that dilute hydrochloric acid was used in excess.47,48 In the
Pharmacopeia method, 4 mL of 2.0 M (eight millimoles) hydrochloric acid was used
because the reaction requires acidic conditions for iron complexation.49 A pH of 0.62
was measured under these conditions. For someone with little training to be able to
perform this test, the acidification process needed to be optimized. Iron hydroxide can
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easily be visually identified as it forms an orange precipitate when the pH is adjusted to
approximately five or greater. By decreasing the HCl concentration to 0.7 M HCl, the iron
maltol complex was still found to be linear (see Figure 11). A weaker acidic condition
was then analyzed to improve the safety of the field assay.
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Figure 11: Beer's Law plot of the current method using 0.7 M HCl.
Acetic Acid Concentration Optimization
HCl concentration was decreased substantially. To continue to make this a safer
method, a weak acid (acetic acid) was analyzed using Beer’s Law (Figure 12).
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Figure 12: Beer's Law plot of the current method with acetic acid instead of hydrochloric
acid.
Using acetic acid as the acid source provides critical improvements to the
assay. As described, pH plays a key role in determining the final complex structure. At
a pH of 1-2, as in the case when HCl was used, the preferred tris(malonato)iron(III)
complex was not formed. Rather, an iron complexed with a mixture of chlorine and
water ligands is proposed. Such an undefined mixture would have a profound impact on
the linearity of a Beer’s Law plot. As shown in Figure 11, a non-linear Beer’s Law plot
was obtained at the low pH assay condition. With acetic acid as the acid source,
however, an assay pH of 3.5 was measured. At this more moderate pH, the
tris(malonato)iron(III) complex was exclusively formed. A singular molecular species
would be confirmed by a linear Beer’s Law analysis. As shown in Figure 12, the novel
assay of this study, using acetic acid as the acid source, produced a highly linear
(R2=0.9932) Beer’s Law plot.
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In addition to improved assay linearity, a five-fold increase in absorbance was
obtained, per mole streptomycin hydrolyzed, with the improved assay procedure of this
study. Two reasons are offered for this higher assay sensitivity. One, the preferred
complex, tris(malonato)iron(III) complex, is formed at high yield without interfering
impurities or mixtures. Secondly, there was more maltol being formed per mole
streptomycin in the base hydrolysis step, as seen in the HPLC results.
Acetic acid, therefore, works well with the current reaction to adjust the pH
enough to form a color complex with maltol and is much safer to use for someone that is
untrained. White vinegar contains 0.8 M acetic acid and this reaction contained 1.0 M
acetic acid, making this a safer reaction than selecting a caustic HCl acid.
HCl vs Acetic Acid Color Complex
When the different acid sources were visually compared, two contrasting colors
were observed. The complex formed when hydrochloric acid was used was purple
(Figure 13) but when acetic acid was used the complex was red (Figure 14).

Figure 13: pH 0.62 iron-maltol solutions with increasing streptomcyin concentrations
made with hydrochloric acid.
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Streptomycin concentrations range from 0 (left) to 1 (right) mg/mL.

Figure 14: pH 3.51 iron-maltol solutions with increasing streptomycin concentrations
made with acetic acid.
Streptomycin concentrations range from 0 (left) to 1 (right) mg/mL.
Red is the color that is described for the iron-maltol complex.46 Previous work
stated that the same iron-maltol complex, formed with the maltol made from the base
hydrolysis of streptomycin is purple when complexed with iron.47,49 These
inconsistencies led to a deeper study of the complexes. The results of this study will be
discussed in Chapter 7.
Metal Salt Analysis
Previous work stated that the iron should be used to form a complex with maltol
yielding a violet color.47–50 It was determined that maltol can complex with other metals to
form different color complexes. These were all analyzed with and without acid, and for
visual analysis, using three different lighting conditions (indoor, outdoor direct and
indirect lighting). Copper, nickel, cobalt, and iron salts were all studied. Only copper and
iron complexes formed a visual color complex (see Figures 15 and 16). Complementary
spectroscopic analysis was conducted to assess assay linearity (see Figure 17 and 18).
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Figure 15: Iron-maltol complexes from 0 (left) to 1 (right) molar streptomycin containing
0.003 M iron.

Figure 16: Copper-maltol complexes from 0 (left) to 1 (right) molar streptomcyin
containing 0.003 M copper.
The Beer’s Law analysis of the iron-maltol complex can be seen in Figure 17 and the
copper-maltol complex can be seen in Figure 18.
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Figure 17: Beer's Law analysis of iron-maltol complex.
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Figure 18: Beer's Law analysis of copper-maltol complex.
Figures 18 and 19 show that the iron-maltol complex was much more linear with
an R2 value of 0.9932 compared to the copper-maltol’s complexes R2 of 0.8131. When
metal and maltol are compared at equal concentrations, the iron complex forms a
response ten times greater than that found with copper. From these results, iron was
determined to be the best metal to use for this test.
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Iron Acetate
To make a test method that requires little-to-no-training iron acetate was studied.
The use of iron acetate decreased the amount of solution preparation required. Instead
of making a 0.37 M ferric chloride solution and having to measure and pipet both the
ferric chloride and acetic acid solutions, iron acetate was investigated.
Paper Test Using Iron Acetate Assay Procedure
The iron acetate reaction results were very dark making it hard to distinguish
between the different solutions. The solutions also contained an undesirable precipitate
from the excess iron acetate. A paper test was developed that would provide two
advantages: one, droplet deposition on paper would result in further separation of the
reaction product from the excess iron acetate through chromatographic diffusion (see
Figure 19); and two, the thinner optical pathlength and white background would enhance
visual discrimination of color differences. The formed color patches could be analyzed
using a reflective spectrodensitometer to determine the optical density, and reaction
linearity.
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Figure 19: Paper assay ranging from 0 to 148 mg/mL streptomycin
These samples were studied in triplicate to test for linearity, the results can be
seen in Figure 20.
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Figure 20: Beer's law analysis of iron-maltol complex on the paper test when solid iron
acetate was added to the solution.
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The paper test made the method much simpler. Due to the iron acetate
precipitate the paper test was used and analyzed using a spectrodensitometer for a
Beer’s Law analysis. The amounts of iron acetate were studied in the range of 0.01 to
0.2 millimolar and the amount that led to the most linear results was determined to be
the optimal amount of iron acetate. This amount was determined to be 0.1 millimolar iron
acetate. Using the solid iron acetate instead of hydrochloric acid changed the pH of the
complex from 1.16 to 7.62.
Capsules
To make the iron acetate addition easier and to facilitate a fool-proof method for
point of care use, the iron acetate was added to the solution via a gelatin capsule.
Gelatin capsules were chosen for safety and ease eliminating the need for measurement
of iron acetate and contact with chemicals. The solution was heated making the gelatin
dissolve in the reaction. The use of gelatin capsules was repeated in triplicate and the
optical density was studied. The Beer’s Law analysis, when the capsules were used, can
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be seen in Figure 21.
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Figure 21: Beer's Law analysis of the iron-maltol complex when gelatin capsules are
used to add the iron acetate.
Testing Common Counterfeit
Counterfeit detection was the purpose for developing this assay. Such an assay
may positively detect the analyte, or positively detect a counterfeit. Detection of the
positive analyte, in purity and dose is preferred. The improved streptomycin test was
compared to many household medications and chalk to make sure the same color was
not produced from any of those reactions from readily available substitutions commonly
used in counterfeit medications. The medications included: magnesium sulfate, generic
allergy tablets, Triphala gold, Aleve, Ibuprofen, and Claritin. A paper test (Figure 22) was
used to compare the results of all of the different medications. This test included six
different concentrations of streptomycin.
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Figure 22: Counterfeit detection test used on common counterfeits.
The inner ring is the excess iron acetate and the outer ring is the color complex.
The excess acetate in all the samples was orange or brown like that of the complex
samples. All the medication samples and chalk are colorless with the exception of
Triphala Gold; not at all matching the samples with streptomycin. Triphala Gold in this
reaction leads to a purple product; this is most likely attributed to an iron-carbohydrate
complex. Though Triphala Gold formed a color complex with iron, it has a distinctively
different visual color. It is important that non-streptomycin samples do not give the same
color results as streptomycin to detect when a “filler” is used in samples.
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Detection of Counterfeit Medications
If the authentication test can be manipulated to give positive results the
counterfeiters will do so (assuming the manipulation is neither too expensive nor
requires significant chemistry knowledge). To avoid the test being manipulated by
adding maltol to the counterfeits, this authentication test can be performed directly on
streptomycin. If iron-acetate is added to streptomycin in water and the paper test is
performed the results will be hexa(aqua)iron (III). This will give an orange precipitate for
the inner circle and the outer circle where the iron-maltol complex is seen, will be
colorless given there is no maltol present. If the test is performed with and without the
hydrolysis step and the results show that the test is negative before the hydrolysis and
positive after the hydrolysis, it can be determined that the streptomycin is authentic.
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Chapter 7
Results: Tris(maltonato)Iron (III) Characterization

During the counterfeit detection test development, solution color from the 1945
method did not match those from the optimized test from this study, as well as, from
tris(maltonato)iron (IIII) complex characterization reports.46,47 The 1945 Schenck method
described a complex derived from streptomycin hydrolysis, and a reported 2007 method
from Pizzanelli et al.46 used maltol extracted from plants. These complexes varied in
visual color -purple in the 1945 method compared with a red color from the Pizzanelli
study. In addition to a significant difference in pH conditions, maltol formation was not
obtained when following the 1945 method, as seen in the HPLC results in Chapter 6.
Counterfeit test validation requires that the products of any chemical test be robustly and
verifiably determined. Detailed, chemical and spectroscopic, analyses were conducted to
resolve the discrepancies between the two methods.
pH Study
Samples were made with a mole ratio of 1:3 (FeCl3: Maltol) ranging in pH from 113 using sodium hydroxide or hydrochloric acid (Figure 23).
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Figure 23: Range of standard iron (III) maltol complexes at different pH’s adjusted with
HCl and NaOH
A purple color was obtained at pH 2. At pH 3 and 4, a red color was formed as described
in the Pizzanelli method. In previous reported studies, the predominate iron-maltol
complex composition was found to be pH dependent.51 A 1:1, iron: maltol complex,
maltonatoiron (III), was determined to be stable at pH 1 and was violet in color. A red 1:2
complex, bis(maltonato)iron (III), is formed at pH 3, and a yellow 1:3 complex,
tris(maltonato)iron(III) complex forms at pH 6.51 Under the conditions of this study, a red
complex was formed in the range of pH 5-9. A yellow complex was not formed until
about pH 10. The change in color from red to yellow will be explained in more detail in
this chapter. The rapid transition, however, at pH 9-10, corresponds with the maltol pKa
(pKa = 8.6). Spectral changes50 have been observed for maltol in this pH range.
Changes in electronic chargstate would be expected to shift the ligand field splitting on
iron (III), and influence solution color. In this case, a stronger field would be exerted by
maltol above pH 9 as evidenced by a shift to a yellow solution color. Also, evident in
Figure 1, was the absence of any iron hydroxide precipitate beyond pH 5.
The chelate effect explains why there are so many colors and complexes (see
Figure 24).
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Figure 24: An example of how the chelate effect influences complex stability.
In Figure 24, a six coordinate metal complex reacts with three bidentate ligands. The
product yields the metal chelated to three bidentate ligands, leaving six free
monodentate ligands. Figure 24 contains four reactants and seven products. The chelate
effect states that such a reaction is entropically driven towards the products.
Chloride and Non-Chloride Containing Acid Analysis
While making the detection method assay the acid was changed from
hydrochloric acid to acetic acid. During this transformation, the color changed from
purple to red. It is known that polymorphic iron chloride is purple and there was excess
chloride when chloride containing acids were used. Chloride and non-chloride containing
acids were analyzed to determine if this polymorphic iron chloride was being formed.
Samples were made of a 1:3 (FeCl3:maltol). These were analyzed by bringing the
color of the reaction to pH 2 with hydrochloric acid, then back pH 4 with sodium
hydroxide and pH 2 with different acids (Figure 25 and 26).
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Figure 25: A tris(maltonato)iron(III) solution was adjusted to pH 2 using HCl (left),
adjusted to pH 4 with NaOH (middle), the same sample adjusted back to pH 2 with HCl
(right).

Figure 26: A tris(maltonato)iron(III) solution was adjusted to pH 2 using HCl (left),
adjusted to pH 4 with NaOH (middle), the same sample adjusted back to pH 2 with
phosphoric acid (right).
These experiments confirm the pH dependent form of the iron complex. In this study,
however, the novel addition of a non-halide containing acid revealed that there is more
explanation required to justify the purple complex result.

48

The spectrochemical series shows that halides are weak field ligands. Weak field
ligands have a small crystal field splitting energy; and therefore, have a red shift in
absorbance. This red shift causes the complex with halides such as chloride to be
purple. In the spectrochemical series the oxalate is very similar to maltol. This has a
stronger field than the halides, causing a larger crystal field splitting energy and a blue
shift. The blue shift in absorbance causes the solution to be red. Water is a stronger field
ligand than the maltol causing it to have an even larger crystal field splitting and shift
more towards the blue explaining the yellow iron hexahydrate. Using the molecular
orbital diagram for octahedral iron complexes further contributes to understanding the
result of a purple complex (Figure 27).

Figure 27: Molecular orbital diagram for octahedral iron complexes
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The colors originate from the d orbitals that are centered on the iron. These orbitals
originate in the d box. The separation in energy is related to the absorbance of color. In
this example a strong field ligand combined with a large crystal field splitting energy
results in a red solution. If the t2g and eg* were closer together, for example with the
halides, then the crystal field splitting energy would decrease causing the solution to
appear purple.
Any complexes formed that were made using an acid containing chloride sources
turned purple and the samples that did not contain a chloride source retained red color.
This led to the conclusion that the purple complex contains chloride ligands. The
spectrochemical series explains how the chlorides are bonding to the iron to form a
polymorphic iron chloride while the red reaction shows the maltol bonded to the iron.
Hydration State of Iron (III) Chloride: A Solid-State Pellet Analysis
Anhydrous and hexahydrate ferric chloride pellets were fabricated and analyzed
using UV-visible spectroscopy reflection and FTIR analysis to determine if the solutionderived purple iron complex could compare with pure chemical standards. The
absorbance vs wavelength (nm) of the ferric chloride hexahydrate (blue) and the
anhydrous ferric chloride pellet (orange) was obtained (Figure 28).
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Figure 28: Reflective absorption spectrum of ferric chloride hexahydrate (blue) and
anhydrous ferric chloride (orange)
The results show that the hexahydrate was yellow, and the anhydrous ferric chloride was
almost black. The FTIR of these chlorides (Figure 29 and 30) allow for further analysis.

Figure 29: FTIR spectrum of ferric chloride hexahydrate
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Figure 30: FTIR spectrum of anhydrous ferric chloride
While the anhydrous ferric chloride pellets were exposed to air, they slowly
turned yellow. As discussed, using HSAB theory, iron is a hard acid and will complex
with water, a hard base. Water is a harder base than chloride ions, therefore iron (III) will
bond to water before it will bond to chloride. Chlorine displacement by water ligands led
to a small water peak in the anhydrous ferric chloride FTIR results (see Figure 30 ).The
FTIR data confirms that the ferric chloride hexahydrate contains water and the
anhydrous ferric chloride does not, causing the yellow and purple colors, respectively
(see Figure 28).
Mole ratios UV-Visible Spectra
The 1945 method and different mole ratios of maltol and ferric chloride were
analyzed at pH 2 (Figure 31) and 5 (Figure 32) with UV-visible spectroscopy and
compared to Gerard et al.52
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Figure 31: UV-visible Spectrum of the 1945 method at pH 2 (yellow) and mole ratios 1:1
(blue), 1:2 (orange), and 1:3 (gray) of ferric chloride: maltol at pH 2.
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Figure 32: UV-visible Spectrum of the 1945 method at pH 5 (yellow) and mole ratios 1:1
(blue), 1:2 (orange), and 1:3 (gray) of ferric chloride: maltol at pH 5
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According to Gerard et al., all the absorbance spectra for all the mole ratio
mixtures at pH 2 (Figure 31) are making the 1:1 complex. At the same time all the mole
ratios at pH 5 (Figure 32) with a 1:3 complexation were being formed. The 1945 samples
do not match any of these complexes of the absorbance spectra, further proving that this
method does not make the complex that was reported. The spectral profiles shown in
Figures 31 and 32 can be explained using a spectrochemical series description.
In reference to the spectrochemical series, halides are weak field ligands.
Oxalates and then water have the strongest field of the three ligand types. When the
ligands are weak field ligands they have a small crystal field splitting energy and exhibit
a red spectral shift.11 For stronger field ligands, larger crystal field
splitting causes spectral shifting toward blue wavelengths. Oxalates are comparable to
maltol in field splitting strength. Tris(malonato)iron(III), therefore, has a red color in
aqueous solution, and hexa(aqua)iron(III) exhibits a yellow color in aqueous
solution. The chlorides have the weakest field causing a red spectral shift, giving a
purple color.
HSAB theory provides that iron (III) is a hard acid and therefore will bond with
hard bases. It is originally bound to water; water is a hard base. It will only bond to the
weaker base (chloride) when chloride is in excess to form a ferric chloride complex.
Although maltol is a softer base than the water or chlorine ligand, maltol is a bidentate
ligand. The iron-maltol reaction, therefore, is entropically driven, following the chelate
effect. The chelate effect states that when a metal bonds to a multidentate ligand the
reaction is entropically driven, favoring disorder.
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FTIR of the Hydrolysis of Streptomcyin
Standard maltol (Figure 33), the 1945 method (Figure 34) and a standard 1:3
mole ratio (Figure 35).

Figure 33: FTIR Spectrum of standard maltol

Figure 34: FTIR Spectrum of the 1945 method
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Figure 35: FTIR of the 1:3 mole ratio (ferric chloride hexahydrate: maltol)
When comparing these spectra, it can be determined that the 1945 method does
not contain maltol. This confirms the HPLC results discussed in Chapter 6 that
determined that the 1945 method was not making maltol during the hydrolysis.
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Chapter 8
Summary and Conclusion
Summary
A colorimetric assay for the TB medication streptomycin was developed. This
assay is rapid, safe, easy, low tech, requires little electricity and can be performed near
the point of care. Counterfeit medications need to be studied as close to the point of care
as possible by someone that is untrained anywhere in the world.
This colorimetric assay is something that is simple, allowing someone that is
untrained to be able to do the analysis. Economically the test enhances the likelihood of
it being performed in developing countries and poor areas in developed countries. This
test is completed through the comparison of colors and therefore would be difficult for
someone to perform if they are color vision deficient. One way to avoid this problem is
having a female perform the test or at least the color comparison because they are much
less likely to be color vision deficient.
The 1945 streptomycin detection test that was used to develop the new
colorimetric assay was then invalidated through a comparative study using FTIR, UVvisible Spectroscopy, and HPLC. These technological processes were also used to
characterize the improved method.
Recommendations for Further Investigations
This streptomycin assay can be improved upon by adding sodium hydroxide as a
solid instead of making a sodium hydroxide solution. This could make the reaction even
easier for someone that is untrained to perform. Using a specified dose amount, a print
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could be made of the drop. The print can then be used for visual comparison without
instrumentation to this test, yet, the detection method is still quantitative.
At this point in the assay’s simplification the print making would need to be tested
with a focus group. Having a focus group, comprised of people having taken no more
than one semester of chemistry to perform this colorimetric assay and the visual test.
The focus group would serve two purposes. First, it would show how simple this test is
for someone that is not trained in chemistry and where it might need to be simplified
even further in the future to make this something that most everyone can do. Secondly, it
will help determine who would need to make the visual comparison given men more
often than women have a color vision deficiency. Finally, statistical analysis needs to be
completed to determine if the test is the same color every time.
There are many different directions that the drug quality assurance (DQA) project
can go in. TB can have multidrug resistant strains.3,24,25 To treat and/or avoid multidrug
resistant TB chemotherapy is performed. Chemotherapy is when multiple medications
are used as a treatment method. If TB streptomycin medication could be counterfeit, so
could other medications used in conjunction with it. The other TB medications will need
detection tests to fully safeguard users.34,53 Therefore the other TB medications need to
have counterfeit detection tests for them as well. Some of the frontline TB medications
that need to be studied are isoniazid, rifampicin, pyrazinamide and ethambutol among
others.
DQA methods are important for all medications but especially important for
commonly counterfeit medications. Unfortunately, since counterfeiting medications are a
two hundred billion dollar industry and still growing, there are many medications that are
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commonly counterfeit.29 The most common types of counterfeit medications include:
cardiovascular medications, antibiotics, cancer medications, ED medications,
medications for chronic ailments (HIV, diabetes and Alzheimer), birth control, painkillers
and weight loss medicines and psychiatric medications.54 From this list it becomes clear
that no medication without a quantitative counterfeit detection method is completely safe.
This is a huge worldwide problem with up to 50% of pharmaceuticals being counterfeit.55
Colorimetric detection can be used to detect trace amounts of dangerous
substances as well. An example would be date rape drugs. Date rape drugs are
commonly put into drinks of people at bars or parties creating great concern in social
situations. They are currently being studied, by many groups, with some products
already currently on the market. Drink Safe Test Coasters is one example.56 There are
additional test methods made but are awaiting FDA approval. These tests include: nail
polish, straws, cups that change colors and paper chips.57
Considering all the products mentioned above for date rape and/or robbery
detection there remains the influence of sociological and economic factors. The methods
that are currently being used are not methods that everyone would be able to easily use.
The coasters, cups, straw and paper chips are all methods requiring the consumer to
bring the test method with them to the bar. This will be an inconvenience to the
consumer but they would not be able to bring just one. These products can only be used
one time and therefore the consumer would have to bring this in excess. Carrying
multiple tests are easier for women than men because most women bring a purse or bag
while most men do not and therefore would have nowhere to store these items while at
the bar. The bars will not pay more money for coasters, straws and paper chips that are
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not reusable. Up to 2000 people were drugged with date rape drugs and then robbed in
the UK alone. When date rape drugs are used in robberies, men are typically the
target.58 The most convenient detection method that has been developed is nail polish,
however, most of the men being drugged and robbed are not going to wear the nail
polish to detect these drugs and therefore there is a need for another way to detect
these drugs. Another problem with the current detection methods is that the drugs that
these detection methods analyze are ketamine and GHB. Flunitrazepam is often
overlooked. A separate test to detect flunitrazepam would have to be bought to test for
all three common date rape drugs. If there was a detection method for all three of these
common date rape drugs that can be used by anyone and is compact and easy to use it
would greatly benefit society.
Colorimetric detection could also be applied to detecting gunshot or explosive
residues in small quantities for efficiency in the field of law enforcement. The current
detection method for gunshot and explosive residues uses analytical techniques such as
a scanning electron microscope.59 There have been colorimetric methods that have
been attempted but are not currently being used because these colorimetric methods did
not detect trace amounts of the residues.59 Making a colorimetric assay that could detect
trace amounts of gunshot or explosive residues earlier in the line of duty would help
officers detain suspects earlier, potentially keeping more people safe.
These colorimetric assays can be useful to detect many different substances for
a worldwide impact. The consequences of counterfeit medications implicate a greater
need for science to study and develop manageable products to safeguard recipients,
reduce drug resistant strains of superbugs, and keeping in check health care costs.
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Lastly, criminal behavior can be subverted or minimized with thoughtful chemical
detection methods.
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